dNovo Bio
San Jose
About dNovo Bio
Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand. Its company's platform converts skin into functional brain cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.7M
- Funding stage: Seed
- Last round: Seed (Jan 2022)
- Website: dnovobio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/dnovo-bio-130004 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.